José L. Cangiano

A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease

Carl J. Pepine, Eileen Handberg, Rhonda M. Cooper‐DeHoff et al. · JAMA · 2003 · 1.3K citations

Medicine, Cardiology, Pharmacology +17

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

Wadi N. Suki, Raja I. Zabaneh, José L. Cangiano et al. · Kidney International · 2007 · 523 citations · Full text

Medicine, Nephrology, Pharmacology +14

Hypertension in End-Stage Renal Disease

Victor Vertes, José L. Cangiano, Leonard B. Berman et al. · New England Journal of Medicine · 1969 · 378 citations

Medicine, Nephrology, Pharmacotherapy +13

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

Robert Provenzano, Anatole Besarab, Chao Sun et al. · Clinical Journal of the American Society of Nephrology · 2016 · 293 citations · Full text

Medicine, Hematology, Pharmacotherapy +14